Literature DB >> 22381157

N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.

Carol P Chong1, Wen Kwang Lim, Elena Velkoska, William J van Gaal, Julie E Ryan, Judy Savige, Louise M Burrell.   

Abstract

The prognostic usefulness of the cardiac biomarkers N-terminal pro-brain natriuretic peptide (NT-proBNP) and angiotensin-converting enzyme 2 (ACE-2), in predicting adverse cardiac outcomes after orthopedic surgery is not well studied. The aim of our study was to determine the usefulness of perioperative NT-proBNP and ACE-2 for predicting cardiac events after emergency orthopedic surgery. The perioperative NT-proBNP and ACE-2 levels were determined in 187 consecutive patients aged >60 years who underwent orthopedic surgery with 1 year of follow-up for any cardiac complications (defined as acute myocardial infarction, congestive cardiac failure, atrial fibrillation, or major arrhythmia) and death. Of the 187 patients, 20 (10.7%) sustained an in-hospital postoperative cardiac complication. The total all-cause in-hospital and 1-year mortality rate was 1.6% (3 of 187) and 8.6% (16 of 187), respectively. The median preoperative and postoperative NT-proBNP level was greater in patients who sustained an in-hospital cardiac event than in those who had not (386 vs 2,273 pg/ml, p <0.001, and 605 vs 4,316 pg/ml, p <0.001, respectively). Similarly, the postoperative median ACE-2 levels were significantly greater in the patients with an in-hospital cardiac event than in those without (25.3 vs 39.5 pmol/ml/min, p = 0.012). A preoperative NT-proBNP level of ≥741 pg/ml (odds ratio 4.5, 95% confidence interval 1.3 to 15.2, p = 0.017), postoperative troponin elevation (odds ratio 4.9, 95% confidence interval 1.3 to 18.9, p = 0.022), and number of co-morbidities (odds ratio 1.8, 95% confidence interval 1.2 to 2.8, p = 0.009) independently predicted in-hospital cardiac complications on multivariate analysis. The pre- and postoperative NT-proBNP level independently predicted 1-year cardiovascular complications but not the ACE-2 levels. In conclusion, elevated perioperative NT-proBNP predicted in-hospital and 1-year cardiac events in an emergency orthopedic population but the ACE-2 levels did not, which requires additional study for validation. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22381157     DOI: 10.1016/j.amjcard.2011.12.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.

Authors:  M Melanie Lyons; Nitin Y Bhatt; Elizabeth Kneeland-Szanto; Brendan T Keenan; Joanne Pechar; Branden Stearns; Nabil M Elkassabany; Stavros G Memtsoudis; Allan I Pack; Indira Gurubhagavatula
Journal:  Biomark Med       Date:  2016       Impact factor: 2.851

2.  Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.

Authors:  Carmen Wolke; Alexander Teumer; Karlhans Endlich; Nicole Endlich; Rainer Rettig; Sylvia Stracke; Beate Fiene; Simone Aymanns; Stephan B Felix; Anke Hannemann; Uwe Lendeckel
Journal:  Exp Biol Med (Maywood)       Date:  2016-12-30

3.  Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide.

Authors:  Pauliina Nordling; Tuomas Kiviniemi; Marjatta Strandberg; Niko Strandberg; Juhani Airaksinen
Journal:  BMJ Open       Date:  2016-02-24       Impact factor: 2.692

Review 4.  Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection.

Authors:  Nazzarena Labò; Hidetaka Ohnuki; Giovanna Tosato
Journal:  Cells       Date:  2020-06-30       Impact factor: 6.600

Review 5.  Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.

Authors:  Eleanor Murray; Maciej Tomaszewski; Tomasz J Guzik
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

6.  Preadmission Statin Prescription and Inpatient Myocardial Infarction in Geriatric Hip Fracture.

Authors:  Seth M Tarrant; Raymond G Kim; Jack M McDonogh; Matthew Clapham; Kerrin Palazzi; John Attia; Zsolt J Balogh
Journal:  J Clin Med       Date:  2021-05-31       Impact factor: 4.241

Review 7.  From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension.

Authors:  Sheila K Patel; Elena Velkoska; Melanie Freeman; Bryan Wai; Terase F Lancefield; Louise M Burrell
Journal:  Front Physiol       Date:  2014-06-24       Impact factor: 4.566

8.  Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.

Authors:  Jay Ramchand; Sheila K Patel; Piyush M Srivastava; Omar Farouque; Louise M Burrell
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.